{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T04:46:00Z","timestamp":1681361160038},"reference-count":47,"publisher":"Georg Thieme Verlag KG","issue":"01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Neurol"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Genetics are fundamental to understanding the pathophysiology of neurological disease, including movement disorders. Genetic testing in clinical practice has changed dramatically over the last few decades. While the likelihood of establishing an etiological diagnosis is greater now with increased access to testing and more advanced technologies, clinicians face challenges when deciding whether to test, then selecting the appropriate test, and ultimately interpreting and sharing the results with patients and families. In this review, we use a case-based approach to cover core aspects of genetic testing for the neurologist, namely, genetic testing in Parkinson's disease, interpretation of inconclusive genetic test reports, and genetic testing for repeat expansion disorders using Huntington disease as a prototype.<\/jats:p>","DOI":"10.1055\/s-0043-1763507","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:13:32Z","timestamp":1677629612000},"page":"147-155","source":"Crossref","is-referenced-by-count":0,"title":["Genetic Testing in Clinical Movement Disorders: A Case-Based Review"],"prefix":"10.1055","volume":"43","author":[{"given":"Lorraine V.","family":"Kalia","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Medicine, Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic and Krembil Research Institute, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graeme A. M.","family":"Nimmo","sequence":"additional","affiliation":[{"name":"Fred A. Litwin Family Centre for Genetic Medicine, Department of Medicine, Mount Sinai Hospital and Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiago A.","family":"Mestre","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa Brain and Mind Research Institute, The Ottawa Hospital, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2023,2,28]]},"reference":[{"issue":"01","key":"ref1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s00415-010-5695-0","article-title":"Deep brain stimulation for camptocormia in dystonia and Parkinson's disease","volume":"258","author":"H H Capelle","year":"2011","journal-title":"J Neurol"},{"issue":"10","key":"ref2","doi-asserted-by":"crossref","first-page":"1923.e1","DOI":"10.1016\/j.neurobiolaging.2011.02.017","article-title":"Heritability of Parkinson disease in Swedish twins: a longitudinal study","volume":"32","author":"K Wirdefeldt","year":"2011","journal-title":"Neurobiol Aging"},{"issue":"01","key":"ref3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1212\/CPJ.0000000000000831","article-title":"Genetic testing for Parkinson disease: are we ready?","volume":"11","author":"L Cook","year":"2021","journal-title":"Neurol Clin Pract"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/B978-0-444-63233-3.00002-6","article-title":"Genetic and genomic testing for neurologic disease in clinical practice","volume":"147","author":"B L Fogel","year":"2018","journal-title":"Handb Clin Neurol"},{"issue":"18","key":"ref5","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1001\/jama.2014.14601","article-title":"Molecular findings among patients referred for clinical whole-exome sequencing","volume":"312","author":"Y Yang","year":"2014","journal-title":"JAMA"},{"issue":"03","key":"ref6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/mdc3.13163","article-title":"Challenges in clinicogenetic correlations: one phenotype - many genes","volume":"8","author":"R Gannamani","year":"2021","journal-title":"Mov Disord Clin Pract (Hoboken)"},{"issue":"05","key":"ref7","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/mds.27045","article-title":"Nomenclature of genetic movement disorders: recommendations of the International Parkinson and Movement Disorder Society task force","volume":"32","author":"C Marras","year":"2017","journal-title":"Mov Disord"},{"issue":"05","key":"ref8","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/mds.28982","article-title":"Nomenclature of genetic movement disorders: recommendations of the International Parkinson and Movement Disorder Society Task Force - an update","volume":"37","author":"L M Lange","year":"2022","journal-title":"Mov Disord"},{"issue":"07","key":"ref9","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.parkreldis.2006.03.002","article-title":"Parkinson's disease and family history","volume":"12","author":"A N Sellbach","year":"2006","journal-title":"Parkinsonism Relat Disord"},{"issue":"07","key":"ref10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","article-title":"Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study","volume":"7","author":"D G Healy","year":"2008","journal-title":"Lancet Neurol"},{"issue":"06","key":"ref11","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/jamaneurol.2013.1925","article-title":"A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies","volume":"70","author":"M A Nalls","year":"2013","journal-title":"JAMA Neurol"},{"issue":"04","key":"ref12","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/acn3.185","article-title":"Variants associated with Gaucher disease in multiple system atrophy","volume":"2","author":"J Mitsui","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"issue":"04","key":"ref13","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/mdc3.12481","article-title":"Frequency of GBA variants in autopsy-proven multiple system atrophy","volume":"4","author":"M Sklerov","year":"2017","journal-title":"Mov Disord Clin Pract (Hoboken)"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.parkreldis.2020.06.007","article-title":"GBA variation and susceptibility to multiple system atrophy","volume":"77","author":"A I Wernick","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"issue":"04","key":"ref15","doi-asserted-by":"crossref","first-page":"e600","DOI":"10.1212\/NXG.0000000000000600","article-title":"Occurrence of amyotrophic lateral sclerosis in type 1 Gaucher disease","volume":"7","author":"L M Oliveira","year":"2021","journal-title":"Neurol Genet"},{"issue":"01","key":"ref16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/mds.26815","article-title":"Study of LRRK2 variation in tauopathy: progressive supranuclear palsy and corticobasal degeneration","volume":"32","author":"M Sanchez-Contreras","year":"2017","journal-title":"Mov Disord"},{"issue":"02","key":"ref17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/mds.27225","article-title":"Clinical and neuropathological features of progressive supranuclear palsy in Leucine rich repeat kinase (LRRK2) G2019S mutation carriers","volume":"33","author":"D Vilas","year":"2018","journal-title":"Mov Disord"},{"issue":"17","key":"ref18","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"E Sidransky","year":"2009","journal-title":"N Engl J Med"},{"issue":"11","key":"ref19","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1002\/mds.23807","article-title":"Kin-cohort analysis of LRRK2-G2019S penetrance in Parkinson's disease","volume":"26","author":"S Goldwurm","year":"2011","journal-title":"Mov Disord"},{"issue":"06","key":"ref20","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1212\/WNL.0000000000000675","article-title":"LRRK2 parkinsonism in Tunisia and Norway: a comparative analysis of disease penetrance","volume":"83","author":"F Hentati","year":"2014","journal-title":"Neurology"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/mds.27059","article-title":"Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non-Ashkenazi Jewish ancestry","volume":"32","author":"A J Lee","year":"2017","journal-title":"Mov Disord"},{"issue":"06","key":"ref22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1212\/WNL.0b013e318245f476","article-title":"Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers","volume":"78","author":"M Anheim","year":"2012","journal-title":"Neurology"},{"issue":"02","key":"ref23","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/gim.2012.107","article-title":"Age-specific Parkinson disease risk in GBA mutation carriers: information for genetic counseling","volume":"15","author":"H Q Rana","year":"2013","journal-title":"Genet Med"},{"issue":"06","key":"ref24","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1001\/jamaneurol.2014.313","article-title":"Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes","volume":"71","author":"R N Alcalay","year":"2014","journal-title":"JAMA Neurol"},{"issue":"11","key":"ref25","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1002\/mds.28200","article-title":"Penetrance of glucocerebrosidase (GBA) mutations in Parkinson's disease: a kin cohort study","volume":"35","author":"R Balestrino","year":"2020","journal-title":"Mov Disord"},{"issue":"02","key":"ref26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41582-019-0301-2","article-title":"LRRK2 in Parkinson disease: challenges of clinical trials","volume":"16","author":"E Tolosa","year":"2020","journal-title":"Nat Rev Neurol"},{"issue":"11","key":"ref27","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/humu.21327","article-title":"Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases","volume":"31","author":"S A Scott","year":"2010","journal-title":"Hum Mutat"},{"issue":"11","key":"ref28","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.3390\/genes12111681","article-title":"Mapping the diverse and inclusive future of Parkinson's disease genetics and its widespread impact","volume":"12","author":"I Elsayed","year":"2021","journal-title":"Genes (Basel)"},{"issue":"42","key":"ref29","doi-asserted-by":"crossref","first-page":"11901","DOI":"10.1073\/pnas.1613365113","article-title":"Deep sequencing of 10,000 human genomes","volume":"113","author":"A Telenti","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"05","key":"ref30","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"S Richards","year":"2015","journal-title":"Genet Med"},{"issue":"01","key":"ref31","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13073-019-0688-9","article-title":"Is \u2018likely pathogenic\u2019 really 90% likely? Reclassification data in ClinVar","volume":"11","author":"S M Harrison","year":"2019","journal-title":"Genome Med"},{"issue":"08","key":"ref32","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/gim.2015.166","article-title":"Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing","volume":"18","author":"L R Susswein","year":"2016","journal-title":"Genet Med"},{"issue":"08","key":"ref33","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/s41436-021-01172-3","article-title":"ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"D T Miller","year":"2021","journal-title":"Genet Med"},{"issue":"06","key":"ref35","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bjae.2021.01.003","article-title":"Anaesthetic management of a known or suspected malignant hyperthermia susceptible patient","volume":"21","author":"P K Gupta","year":"2021","journal-title":"BJA Educ"},{"issue":"03","key":"ref36","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1474-4422(21)00462-2","article-title":"Whole genome sequencing for the diagnosis of neurological repeat expansion disorders in the UK: a retrospective diagnostic accuracy and prospective clinical validation study","volume":"21","author":"K Iba\u00f1ez","year":"2022","journal-title":"Lancet Neurol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/B978-0-444-63233-3.00009-9","article-title":"Repeat expansion diseases","volume":"147","author":"H Paulson","year":"2018","journal-title":"Handb Clin Neurol"},{"issue":"05","key":"ref38","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/ejhg.2012.200","article-title":"EMQN\/CMGS best practice guidelines for the molecular genetic testing of Huntington disease","volume":"21","author":"M Losekoot","year":"2013","journal-title":"Eur J Hum Genet"},{"issue":"01","key":"ref39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/mds.870110128","article-title":"Phenytoin-induced focal chorea","volume":"11","author":"L M Shulman","year":"1996","journal-title":"Mov Disord"},{"issue":"12","key":"ref40","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1038\/gim.2014.146","article-title":"American College of Medical Genetics and Genomics Standards and Guidelines for Clinical Genetics Laboratories, 2014 edition: technical standards and guidelines for Huntington disease","volume":"16","author":"L Bean","year":"2014","journal-title":"Genet Med"},{"key":"ref41","volume-title":"Huntington Disease","author":"N S Caron","year":"1993"},{"issue":"05","key":"ref42","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/mds.21915","article-title":"Huntington's disease phenocopies are clinically and genetically heterogeneous","volume":"23","author":"E J Wild","year":"2008","journal-title":"Mov Disord"},{"issue":"04","key":"ref43","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/cge.12283","article-title":"Huntington disease and Huntington disease-like in a case series from Brazil","volume":"86","author":"R M Castilhos","year":"2014","journal-title":"Clin Genet"},{"issue":"04","key":"ref44","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1212\/WNL.0000000000000061","article-title":"C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies","volume":"82","author":"D J Hensman Moss","year":"2014","journal-title":"Neurology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/brain\/awg155","article-title":"Huntington's disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes","volume":"126","author":"G Stevanin","year":"2003","journal-title":"Brain"},{"issue":"09","key":"ref46","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/jamaneurol.2016.2215","article-title":"Expanding the spectrum of genes involved in Huntington disease using a combined clinical and genetic approach","volume":"73","author":"L L Mariani","year":"2016","journal-title":"JAMA Neurol"},{"issue":"03","key":"ref47","first-page":"203","article-title":"Searching for mutation in the JPH3, ATN1 and TBP genes in Polish patients suspected of Huntington's disease and without mutation in the IT15 gene","volume":"42","author":"A Su\u0142ek-Piatkowska","year":"2008","journal-title":"Neurol Neurochir Pol"},{"issue":"21","key":"ref48","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1212\/01.wnl.0000269323.21969.db","article-title":"Are interrupted SCA2 CAG repeat expansions responsible for parkinsonism?","volume":"69","author":"P Charles","year":"2007","journal-title":"Neurology"}],"container-title":["Seminars in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0043-1763507.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T13:17:53Z","timestamp":1681305473000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0043-1763507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":47,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2023,4,3]]},"published-print":{"date-parts":[[2023,2]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0043-1763507","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0271-8235","1098-9021"],"issn-type":[{"value":"0271-8235","type":"print"},{"value":"1098-9021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2]]}}}